Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Emerging Neurotechnology Startups to Present at 2023 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Among the new and emerging neurotech firms presenting at the conference are Opto Biosystems, a U.K. developer of novel diagnostics for brain cancer, NeuraLace Medical, a San Diego-based manufacturer of noninvasive therapies for treating chronic pain, Spark Biomedical, a Texas firm developing noninvasive therapies for treating addiction, and Harmonic Pain Solutions, an Atlanta, GA-area developer of wearable pain devices that use mechanical stimulation.

Jim Schuermann, president and CEO of Saluda Medical, will deliver the keynote address on the morning of November 6. He will speak on the topic "New Directions in Neuromodulation."

Daniel Kraft, founder of NextMed Health, chair of medicine for Singularity University, and chair of the XPrize Pandemic & Health Alliance, will deliver a keynote address on November 7 devoted to the topic, "The Future of Health and Medicine: Where Can Technology Take Us?" Kraft is board certified in internal medicine and pediatrics and completed fellowships in hematology/oncology and bone marrow transplantation at Stanford. He has given six TED & TEDMED talks.

Another featured presenter will be Prasad Shirvalkar, an associate professor at UC San Francisco School of Medicine, who recently co-authored a seminal paper relating to pain biomarkers. Chris Rozell, a professor at Georgia Tech, who recently coauthored a paper on biomarkers for depression, will also make a presentation at the event.

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled "Neurotech Investment: Bouncing Back from the Downturn," which will feature advice and recommendations from several venture capital professionals, including Sara Shnider from Joy Ventures, Martin Dieck from Neurotechnology Investors, and Suraj Mudichintala from Action Potential Venture Capital.

Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled "Changing Landscape: New SCS and PNS Vendors Enter the Scene," which will examine the current competitive environment in neuromodulation. Neurotech Reports editor James Cavuoto will moderate a session titled "Interpreting the Data: Neuromodulation Vendors Ward Off Negative Publications. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled "Choosing Our Role Models: What Neurotech Can Learn from Other Healthcare Industries."

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic, Velentium, Focus, Neo-Bionica, and Iris Biomedical are Silver Sponsors, while TTP and Microdul are Bronze sponsors.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html

Related link: https://www.neurotechreports.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Mudit Jain, Ph.D., general partner at VC firm Treo Ventures, will keynote the conference. Dr. Jain has more than two decades of medical device industry experience across company formation, R&D, business development, and venture capital, with a global perspective on healthcare based on his experiences in the U.S., Ireland, and India. He is the co-founder of NuXcel, a medical device accelerator, and also serves as chairman of the board of ShiraTronics Inc., a NuXcel spinoff. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

"The neurotechnology industry has emerged as one of the most promising areas of healthcare technology, and Neurotech Reports has been following the space longer than any other organization," said James Cavuoto, editor and publisher at Neurotech Reports. "This year's conference-our 22nd annual-will offer unique insights for management and investment professionals involved with the industry."

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to reimbursement, securing funding, the new competitive landscape in neuromodulation, deep-brain stimulation, and neurorehabilitation. New this year is a session devoted to privacy, security, and ethics in neurotechnology.

Among the companies presenting this year are gBrain, a Korean manufacturer of graphene-based brain engineering systems, Motif Neurotech, a Texas developer of compact implanted brain stimulation devices for treating depression, and REVAI, a Canadian manufacturer of AI-powered vagus nerve stimulation systems for learning and wellness applications. Other presenting companies are Neural Dynamics Technologies, NeuroSigma, Roga Life, NXTStim, PathMaker Neurosystems, NeuronOff, WISE Srl, Sana Health, and Zeto Inc.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic and MCRA are Silver Sponsors, and the Cleveland FES Center is Bronze Sponsor.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html.

Related link: https://www.neurotechreports.com/

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Books and Publishing, Business, Free News Articles, Product Launches

Neurotech Reports Announces Launch of New Publication Serving Bioelectronic Medicine Industry

SAN FRANCISCO, Calif. -- Neurotech Reports, the San Francisco, California publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report, is the first industry newsletter devoted to bioelectronic medicine, which refers to the therapeutic use of electrical or other forms of stimulation, rather than drugs, to treat disorders.

The publication was introduced at the Neurotech Leaders Forum, which takes place November 8-9, 2021 in San Francisco.

James Cavuoto, editor and publisher at Neurotech Reports, said that bioelectronic medicine promises to alter fundamentally the nature of therapeutic interventions for treating a wide variety of conditions, ranging from inflammatory disorders to bowel and bladder disorders, and a host of other potential markets in which drug therapies have fallen short. "We plan to be the most up-to-date and authoritative source of information and analysis of the market, the major players, deal activity, and important clinical research in bioelectronic medicine," he said.

Cavuoto is the lead author of Neurotech Report's market research study, "The Market for Bioelectronic Medicine: 2022-2027." Neurotech Reports launched the Bioelectronic Medicine Forum in New York City in 2018, and plans to return to New York for the fifth annual event in April 2022.

Helping launch the new publication is consulting editor Susan Schaeffer, former editor of BioCentury, the leading industry newsletter for the pharmaceutical industry. In that role, she advanced new thinking in clinical trial development, regulation, pricing, and market access-factors that will be critical in bioelectronic medicine. She is also a member of the National Academies Forum on Drug Discovery, Development, and Translation and founder of a patient education nonprofit.

"Bioelectronic medicine is rapidly bringing a new modality forward for targeted and personalized medicine-a space that has been dominated by biopharmaceutical companies," said Schaeffer. "BioElectRx Business Report will have a particular focus on the potential for collaboration between these historically separate sectors, and will shed light on the potential of this new technology to treat serious diseases, either without, or in conjunction with drugs."

Contributing editor Jo Jo Platt, who has worked with many bioelectronic medicine pioneers during her career, will round out the editorial team for BioElectRx Business Report.

For more information on subscribing to BioElectRx Business Report, contact Neurotech Reports at 1-415-546-1259, or visit: https://www.neurotechreports.com/pages/BioElectRx-newsletter.html

For more information on Neurotech Reports, visit: https://neurotechreports.com/

Learn more about the Neurotech Leaders Forum at: https://neurotechreports.com/pages/leadersforum.html

Related link: http://www.neurotechreports.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Fifteen Neurotechnology Startups to Present at the 2019 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Josh Makower, general partner at VC firm New Enterprise Associates, will keynote on the first day of the conference. Makower is cofounder of the Stanford Byers Biodesign Center and also founder and executive chairman of ExploraMed, a medical device incubator that has created eight companies over the past 20 years.

Robert Knight, professor of psychology and neuroscience and director emeritus of the Helen Wills Neuroscience Institute at UC Berkeley, will deliver the keynote on the second day of the event. Knight is the recipient of the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health for distinguished contributions to neurological research. He is also the chief science advisor of Neurofocus Inc., the consumer neurotech spinoff company acquired by market research firm Nielsen.

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to clinical trials, securing funding, the new competitive landscape in neuromodulation, closed-loop stimulation, and neurorehabilitation. New this year is an editorial roundtable featuring Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta, who will each offer their perspectives on issues confronting the industry.

Among the companies presenting this year are Saluda Medical, Nia Therapeutics, Neuroelectrics, Humm, Evoke Neuroscience, Neural Dynamics Technologies, Spark Biomedical, Thermaquil, Humm, Neuraura, CareWear, Rune Labs, Neural Signals, and BIOS.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Maynard Cooper and Integer are Silver Sponsors, and RBrooks Group, Senso Medical, and the Cleveland FES Center are Bronze Sponsors.

"We're excited about the lineup of speakers at this year's event," said James Cavuoto, editor and publisher at Neurotech Reports. "As in the past, attendees will have many opportunities to interact with potential partners and colleagues."

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/leadersforum.html.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Neuroprosthetics Pioneer to Keynote at the 2018 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. -- Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Peckham is a Distinguished University Professor and Donnell Institute Professor of Biomedical Engineering at Case Western Reserve University. He is also associate director of technology transfer at the Cleveland FES Center and the founder of the Institute for Functional Restoration. The event will take place October 15-16 in San Francisco, Calif.

Frank Fischer, CEO of NeuroPace Inc., has also been added to the agenda as a keynote speaker. Other additions include Eddie Chang, co-director of the Center for Neural Engineering at UC Berkeley and UC San Francisco, Philip Starr, professor of neurosurgery at UCSF, Michael Ackermann, CEO of Presidio Medical, Bashar Badran from the U.S. Army Research Laboratories, Cristin Welle, a former FDA employee and now assistant professor at University of Colorado, Nick Langhals, Neural Engineering Program Manager at the National Institutes of Health, and John Donoghue, director of the Wyss Center for Neuro and Bioengineering.

Executives from several early-stage and emerging neurotech startups will also make presentations during the event. These include Manfred Franke, founder and CEO of Neuronoff Inc., Bill Edelman, chairman of Highland Instruments, Erik Nilsen, CEO of Bio-Signal Technologies, LLC, and Howard Leonhardt, CEO of CerebraCell.

The conference returns to the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif. Platinum Sponsor at this year's conference will be Cirtec Medical. Micro Systems Technologies is the Gold Sponsor. Other sponsors include IMEC, Cactus Semiconductor, Hereaus, Senso Medical, RBrooks Group, Maynard Cooper, Cleveland FES Center, along with partners the International Neuromodulation Society and Neuromodec.

"We're pleased to have such a distinguished lineup of speakers at the 2018 Neurotech Leaders Forum," said James Cavuoto, editor and publisher of Neurotech Reports. Neurotech Reports, founded in 2001, is the leading and longest-established publishing and market-research firm covering the neurotechnology industry.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/leadersforum.html.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Regional Events, Surgery and Neurotechnology

Key Startups and Industry Figures to Present at 2016 Neurotech Leaders Forum

SAN FRANCISCO, Calif. -- Several promising neurotechnology firms and key industry figures will present at the 2016 Neurotech Leaders Forum. The 16th annual event will take place October 24-25 in San Francisco, presented by Neurotech Reports. Keynote speaker at this year's event on October 24 will be Doug Weber, who serves as program manager for DARPA's Biological Technologies Office. Prior to joining DARPA, Weber was an associate professor of bioengineering at the University of Pittsburgh. He received his Ph.D. in bioengineering at Arizona State University.

On October 25, Adam Roth, Director of Business Development at Galvani Bioelectronics, will speak on the topic of bioelectronic medicine. Galvani was formed earlier this year as a joint venture between Google's Verily Life Sciences Unit and pharmaceutical giant GSK.

Other presenters at this year's conference are Jason Richey, president of LivaNova's neuromodulation unit, Jeff Kramer, vice president of research at St. Jude Medical Neuromodulation, David Hankin, CEO of the Alfred Mann Foundation, Frank McEachern, CEO of MicroTransponder, Inc., Aaron Kaluszka, research engineer at Lumos Labs, and Gaurav Sharma, principal research scientist at Battelle.

Neurotech entrepreneurs and startups presenting at the conference include Milton Morris, CEO of NeuSpera Medical, Roy Katz, vice-president at BlueWind Medical, Brian Blischak, president of Nexeon MedSystems, Howard Leonhardt, CEO of CerebraCell, and Chris Czura, CSO of Sanguistat.

The conference moves to a new location this year, the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif.

Platinum Sponsor at this year's conference will be Micro Systems Technologies. Cirtec Medical is the Gold Sponsor. Stellar Technologies is the Silver Sponsor.

For more information on the Neurotech Leaders Forum, contact Neurotech Reports at 415-546-1259.

The preliminary agenda is online at: http://www.neurotechreports.com/pages/nlfagenda.html.

Overview of the 2016 Neurotech Leaders Forum: http://neurotechreports.com/pages/leadersforum.html.

*PHOTO for Media: Send2Press.com/mediaboom/16-1010s2p-ntleaders-300dpi.jpg

*Photo Caption: The Neurotech Leaders Forum returns to San Francisco October 24-25.

This news story was published by the Neotrope® News Network - all rights reserved.